Restrictions in use of cyproterone acetate due to risk of meningioma
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
|Therapeutic area (MeSH)||
Referral - Article 31
Cyproterone-containing medicinal products